/Companies

Endoron Medical

Founded 2019 · 14 employees on LinkedIn · 1 known investors

Find your way into Endoron Medical

Sign up to see every warm intro you have to Endoron Medical

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Endoron Medical team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Endoron Medical develops transcatheter anchoring and sealing devices for aortic procedures, including Aortodock (a nitinol docking system to stabilize transcatheter valves in low-calcium aortic regurgitation and stenosis anatomies) and Aortoseal (a multi-stapling fixation and sealing system for endovascular aneurysm repair grafts). Its products serve physicians treating patients across the aortic continuum from TAVR to EVAR.

Investors · 1

Funding

SEC filings, press & company announcements

$10M disclosed across 1 of 2 rounds · 2024

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Endoron Medical do?
Endoron Medical develops transcatheter anchoring and sealing devices for aortic procedures, including Aortodock (a nitinol docking system to stabilize transcatheter valves in low-calcium aortic regurgitation and stenosis anatomies) and Aortoseal (a multi-stapling fixation and sealing system for endovascular aneurysm repair grafts). Its products serve physicians treating patients across the aortic continuum from TAVR to EVAR.
Who are Endoron Medical's investors?
Endoron Medical's investors include Sofinnova Partners.
How much funding has Endoron Medical raised?
Endoron Medical has disclosed $10M raised across 1 of its 2 known rounds.